Catechol-O-methyltransferase (COMT) was first described by Axelrod et al., 1 who later partially purified and characterized this important enzyme. 2 COMT is responsible for the O-methylation of catecholamines resulting in modulation and increase in dopamine levels in the prefrontal cortex. [3] [4] [5] Recent reports consider COMT as an important gene; which may be involved in cognition, modulation of prefrontal cortex and genetic predisposition towards schizophrenia. 5 There is one single gene for COMT, which codes for both soluble and membrane-bound isoforms of COMT. 3 Genetic polymorphisms have also been described associating COMT activity with several other neuropsychiatric conditions such as obsessivecompulsive disorder, antisocial behavior, late-onset alcoholism and rapid cycling bipolar disorder. 3 Brain COMT is present in neurons, 6 glial 7 and ependymal cells. 6 The soluble COMT is localized to the cytosol and nucleus whereas the membrane-bound COMT is present in the endoplasmic reticulum. 3 Male COMT knockout mice lack COMT activity and exhibit a threefold increase in dopamine levels in the frontal cortex. 8 Subjects with velocardiofacial syndrome, who have a COMT deletion at chromosome 22q11, exhibit a higher incidence of schizophrenia. 5 Recent experiments performed in our laboratory evaluated the effects of chronic administration of several psychotropic agents such as clozapine (20 mg/kg/day), fluoxetine (10 mg/kg/day), haloperidol (1.5 mg/kg/day), lithium chloride (50 mg/kg/day), olanzapine (2 mg/kg/day), sodium valproate (300 mg/ kg/day) versus saline, on brain gene regulation, in male Sprague-Dawley albino rats. Animals were randomly assigned to one of the six drug groups or sterile saline and administered drugs or diluent intraperitoneally for 21 days. The University of Minnesota Animal Care Committee approved all experimental procedures. Animals were killed, brains were removed and frontal cortices were dissected and flash-frozen in liquid nitrogen and stored at À801C for future assays. The tissues were then homogenized and analyzed for DNA and protein levels using DNA microarray technique or sodium dodecyl sulfatepolyacryl amide gel electrophoresis and Western blotting, respectively, following previous procedures. 9, 10 Differences for all protein levels for COMT were normalized against b-actin and assayed using a Student's t-test. Significant differences are defined as those with a P-value < 0.05.
Microarray results showed a significant (P < 0.05), twofold decrease in mRNA for COMT in all drug treatment groups (except for olanzapine) when compared with controls ( Table 1 ). The soluble COMT (24 kDa band) was significantly downregulated in the frontal cortex by clozapine (P = 0.014), lithium (P = 0.0006), olanzapine (P = 0.046) and sodium valproate (P = 0.0073; Figure 1) ; was significantly upregulated by fluoxetine (P = 0.0063); and unaffected by haloperidol (Table 1 ). In contrast, the membranebound COMT (28 kDa band) was downregulated significantly (P = 0.0073) by sodium valproate only ( Figure 1 and Table 1 ).
There were no statistically significant differences in the levels of b-actin in any of the drug-treated brains versus controls, indicating absence of any major treatment-related effects on protein stability. Thus, only two drug-treated groups showed differences between their mRNA and corresponding protein products, that is, fluoxetine showed a significant downregulation of COMT mRNA and a significant upregulation of its protein product. Similarly, haloperidol downregulated mRNA for COMT significantly but this did not affect COMT protein product. In the case of olanzapine, although DNA for COMT was not determined its soluble protein product decreased significantly (Table 1 ).
In conclusion, these results show that COMT is a key target of all three classes of psychotropic agents and may be partially responsible for improvements in frontal cortex dopamine-dependent functions such as working memory performance in subjects treated with these agents. Figure 1 Effects of psychotropic agents on COMT expression in rat frontal cortex. A, C, E, G, I and K correspond to protein levels from frontal cortices of clozapine-, fluoxetine-, haloperidol-, lithium-, olanzapine-and sodium valproatetreated rat brains, respectively. B, D, F, H, J and L correspond to protein levels from frontal cortices of saline-treated rat brains, respectively.
